The evidence from the previous research indicates that NGAL could facilitate an AKI diagnosis in adult critically ill patients 48 h earlier than the Risk, Injury, and Failure, and Loss, and End-stage kidney disease, or RIFLE, criteria [10]. The gene discussed is LCN2; the disease is acute kidney injury.